GlassScriptPhysician profile
David Badi Thurber
NPI 1689921710
$7,844.52
in general payments reported to CMS, 2019-2025
6 companies · $1,055 in 2025
The $1,055 reported for 2025 was more than what 87% of Oral and Maxillofacial Surgery providers received nationally (typical 2025 total: $150).
See the full distribution for Oral and Maxillofacial Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $75.00 · 2021: $360 · 2022: $1,908 · 2023: $1,314 · 2024: $3,132 · 2025: $1,055.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,639 · Entertainment: $931 · Travel and Lodging: $931.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,639.03 |
| Entertainment | $931.08 |
| Travel and Lodging | $931.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Keystone Dental INC. | $4,445.57 | 2022-2024 | |
| Biohorizons Implant Systems INC. | $1,714.37 | 2022-2025 | Biohorizons, Biohorizons Dental Implants |
| Geistlich Pharma, North America, INC. | $1,042.89 | 2024-2025 | Vallos, No Product, Biomaterials |
| Nobel Biocare USA | $555.92 | 2020-2023 | Nobelactive |
| Salvin Dental Specialties, INC. | $63.25 | 2021 | |
| Patterson Companies, INC. | $22.52 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Thurber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.